VAXXINITY, INC. (a Delaware corporation) 6,000,000 Shares of Class A Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 17th, 2021 Company Industry Jurisdiction
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 8th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [ ], 2021 between Vaxxinity, Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
ContractWarrant Agreement • November 5th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 5th, 2021 Company Industry JurisdictionTHIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.
REGISTRATION RIGHTS AGREEMENT BY AND AMONG VAXXINITY, INC. AND THE “INVESTORS”, as defined herein November 15, 2021Registration Rights Agreement • November 17th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 17th, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of November 15, 2021, by and among Vaxxinity, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
REGISTRATION RIGHTS AGREEMENT BY AND AMONG VAXXINITY, INC. AND THE “INVESTORS”, as defined hereinRegistration Rights Agreement • November 5th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 5th, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of [ ], 2021, by and among Vaxxinity, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
VOTING AGREEMENTVoting Agreement • October 8th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 8th, 2021 Company Industry Jurisdiction
PLATFORM LICENSE AGREEMENT Dated as of August 5, 2021Platform License Agreement • October 8th, 2021 • Vaxxinity, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionThis Platform License Agreement (this “Agreement”), dated as of August 5, 2021 (the “Effective Date”), is entered into between the following parties:
OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • August 9th, 2023 • Vaxxinity, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2023 Company Industry